Impacto Públicocivic observatory
Portuguêspt-PTEnglishcurrent languageEspañoles-ES

PUBLIC CONTRACT · 2022

Pq/19/2023 derivados do plasma humano

Contract value
€15,600.00
Signed on
20 December 2022
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9636044

PUBLISHED SUBJECT

PQ/19/2023 DERIVADOS DO PLASMA HUMANO

WHO CONTRACTED

Parties involved

Place of performance
Portugal, Lisboa, Lisboa
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
BAXTER MEDICO FARMACEUTICA LDA · Tax ID 503347345
Bidder
CSL BEHRING · Tax ID 503047201
Bidder
Octapharma-Prod Farmacêuticos, Lda · Tax ID 502820780
Bidder
GRIFOLS PORTUGAL · Tax ID 502041285

HOW MUCH AND WHEN

Values and timeline

Contract price
€15,600.00
Procedure base price
€377,851.60
Total effective price
Not reported on Portal BASE
Publication date
26 December 2022
Award date
20 December 2022
Signing date
20 December 2022
Performance period
365 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Monofator
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement
CP 2020/9 - Derivados do plasma humano
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
6114686

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts